These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12430239)

  • 41. Diabetic nephropathy.
    Shlipak M
    Clin Evid; 2004 Dec; (12):814-33. PubMed ID: 15865682
    [No Abstract]   [Full Text] [Related]  

  • 42. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
    Schnack C; Schernthaner G
    Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diabetic nephropathy].
    Sasaki M; Shikata K; Makino H
    Nihon Rinsho; 2006 Sep; Suppl 3():169-74. PubMed ID: 17022524
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The treatment of arterial hypertension in diabetes mellitus. Choices and problems].
    Orsini S; Allegri L; Castiglioni A; Garini G; Vinci S; Savazzi G
    Recenti Prog Med; 1993 Dec; 84(12):873-83. PubMed ID: 8108603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
    Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
    Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prospective treatment study of irbesartan. Diabetic kidneys regain function].
    Lehnert H; Bramlage P; Pittrow D; Kirch W
    MMW Fortschr Med; 2003 Oct; 145(41):41. PubMed ID: 14655481
    [No Abstract]   [Full Text] [Related]  

  • 49. EC approves irbesartan for the treatment of diabetic renal disease.
    Cardiovasc J S Afr; 2002; 13(4):216-7. PubMed ID: 12402931
    [No Abstract]   [Full Text] [Related]  

  • 50. [Considerations on the treatment of incipient diabetic nephropathy (lst of 2 parts)].
    Pérez Blanco FJ; Manzanares L; Moreno G; Cabello MJ
    An Med Interna; 1996 Apr; 13(4):193-7. PubMed ID: 8688481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microalbuminuria in diabetes mellitus.
    Tobe SW; McFarlane PA; Naimark DM
    CMAJ; 2002 Sep; 167(5):499-503. PubMed ID: 12240818
    [No Abstract]   [Full Text] [Related]  

  • 52. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
    Zimlichman R
    Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
    [No Abstract]   [Full Text] [Related]  

  • 53. A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension.
    Palmer AJ; Valentine WJ; Tucker DM; Ray JA; Roze S; Annemans L; Lapuerta P; Chen R; Gabriel S; Carita P; Rodby RA; de Zeeuw D; Parving HH; Laville M
    Curr Med Res Opin; 2006 Nov; 22(11):2095-100. PubMed ID: 17076969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Albuminuria reduction: the holy grail for kidney protection.
    Tuttle KR
    Kidney Int; 2007 Oct; 72(7):785-6. PubMed ID: 17882241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nephroprotection in diabetes mellitus.
    Singh NK
    Clin Exp Hypertens; 1999; 21(1-2):85-94. PubMed ID: 10052645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diabetic patients have to be tested regularly for microalbuminuria. Almost every second one has already kidney damage].
    MMW Fortschr Med; 2004 Jan; 146(5):47. PubMed ID: 15035422
    [No Abstract]   [Full Text] [Related]  

  • 57. [Progress on diagnosis and therapy of diabetic nephropathy].
    Kitsukawa R
    Nihon Naika Gakkai Zasshi; 1996 Apr; 85(4):546-50. PubMed ID: 8708472
    [No Abstract]   [Full Text] [Related]  

  • 58. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies].
    Katayama S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740
    [No Abstract]   [Full Text] [Related]  

  • 59. Diabetic renal disease: microalbuminuria, implications and intervention.
    Savage MW; Leese GP; Vora JP
    Nutrition; 1995; 11(6):761-4. PubMed ID: 8719137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How different urinary albumin excretion rates can predict progression to nephropathy and the effect of treatment in hypertensive diabetics.
    Llewelyn DE; Garcia-Puig J
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):141-5. PubMed ID: 15526250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.